# LASTACAFT

NDC: 0023-4290
Generic name: alcaftadine
Labeler / Manufacturer: Allergan, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20101101

FDA application: NDA022134

## Active ingredients

- ALCAFTADINE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0023-4290"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0023-4290
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17d37e8d-7825-424b-b6ca-0a85d0bf4694